Clinical
What do pharmacists need to know?
Australian researchers have reviewed the evidence behind nicotine vaping products as a harm reduction tool and provide advice for pharmacy staff Pharmacists play a critical role in delivering harm reduction …
More safety data needed
Another trial confirms active sunscreen ingredients are systematically absorbed into the body, as FDA calls for more data to establish the safety of 12 ingredients A randomised clinical trial has …
Bushfire smoke is bad for eyes, too
As we continue to contend with smoke haze in various parts of the country, many Australians may find themselves with watery, burning, irritated or red eyes Katrina Schmid Associate Professor, …
Q&A: What pharmacists should know about gut health
AJP speaks with pharmacist John Bell about the latest in children’s gut health and related allergies 1. What do pharmacists need to know about cows’ milk allergy and kids? Cows’ …
Large review finds positive pharmacy impact
Community pharmacy-based interventions most likely have a positive effect on health behaviours, intermediate clinical outcomes and quality of life in patients, Cochrane review finds The Cochrane review set out to …
Toxic oils
Cases of poisoning from essential oil exposure are frequent and increasing in Australia, new research reveals A study published this week shows there were 4,412 calls made to the NSW …
New biosimilars listed on the PBS
Here’s what you need to know While there are not many biosimilars available yet in Australia, several have been added to the ARTG and PBS this year. Biosimilar medicines are …
How can pharmacists help to prevent falls?
New research from Monash University links falls with medication initiation and dose changes Researchers from Monash University’s Centre for Medicine Use and Safety (CMUS) have conducted a root cause analysis …
‘These are very reassuring results.’
Longest observational study to date finds no association between statin use and decline in memory or cognition New research has found no association between statin use and memory change in …
Opioid intervention coverage ‘woefully inadequate’
It would be “fantastic” if more pharmacists were willing to provide opioid replacement therapy, says leading researcher Latest data estimates that 40.5 million people across the world were dependent on …
Product shortages
TGA releases list of Ranitidine products impacted by recall Ranitidine tablets and oral liquids are now in short supply as a number of commonly-used brands have been recalled from pharmacies, …
How does stockpiling, dependence and diversion relate to dose?
A study across patients recruited from Australian community pharmacies has looked at the link between prescribed opioid dose and problematic behaviours Many people stay on opioids for years to treat …